SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE
0410.572.888 · rovalta.com · 29/09/2026
SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOSOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE is a Non-profit organization incorporated in 1969. Its main activity is: Other human health activities. Its registered office is in Uccle.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0410.572.888
- Incorporation
- 13/02/1969
- Legal form
- Non-profit organization
- Registered office
- Avenue Winston Churchill 11 box 30
1180 Uccle · BruxellesSee on map - Latest accounts
- 31/12/2025
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 705,8 k € | +20.4% | 586,2 k € | +15.6% | 507,2 k € | +10.7% | 458,1 k € | -24.1% | 603,4 k € |
| EBITDA | -353,1 k € | -293% | 183,4 k € | -10.7% | 205,5 k € | +381% | 42,7 k € | +308% | -20,5 k € |
| Operating result | -353,1 k € | -293% | 183,4 k € | -10.7% | 205,3 k € | +402% | 40,9 k € | +283% | -22,4 k € |
| Net result | -348,8 k € | -285% | 188,1 k € | -11.9% | 213,5 k € | +569% | 31,9 k € | +236% | -23,5 k € |
| Balance sheet | |||||||||
| Equity | 1 M € | -25.7% | 1,4 M € | +16.1% | 1,2 M € | +22.3% | 957 k € | +3.5% | 925 k € |
| Total assets | 1,5 M € | -0.8% | 1,5 M € | +26.6% | 1,2 M € | -6.9% | 1,3 M € | +1.0% | 1,3 M € |
| Cash | 711,2 k € | +14.4% | 621,7 k € | -12.1% | 707,2 k € | +10.9% | 637,5 k € | +21.2% | 525,9 k € |
| Debts | 499,2 k € | +182% | 177,1 k € | +279% | 46,8 k € | -44.7% | 84,5 k € | +296% | 21,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/202520 active · 15 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Charlotte Baert | Director17/11/2020 → 01/09/2028 | ||
Clio Ribbens | Director19/09/2024 → 01/09/2028 | ||
Isabelle de Wergifosse | Director17/11/2020 → 01/09/2028 | ||
Jan Lenaerts | Director17/11/2020 → 01/09/2028Chairman of the board of directors17/11/2020 → 2023 accountsended | ||
Karin Melsens | Director19/09/2024 → 01/09/2028 | ||
Laurent Meric de Bellefon | Chairman of the board of directors19/09/2024 → 24/09/2026Voorzitter19/09/2024 → 2024 accountsendedDirector17/11/2020 → 2023 accountsended | ||
Nicolaas Aerts | Director19/09/2024 → 01/09/2028 | ||
Olivier Malaise | Director19/09/2024 → 01/09/2028 | ||
Patrick Durez | Director17/11/2020 → 01/09/2028Penningsmeester19/09/2024 → 2024 accountsended | ||
Patrick Verschueren | Director19/09/2024 → 01/09/2028Vice-chairman of the board of directors17/11/2020 → 2023 accountsended | ||
Philip Remans | Director19/09/2024 → 01/09/2028 | ||
Rik Dories | Director19/09/2024 → 01/09/2028 | ||
Vanessa Smith | Director19/09/2024 → 01/09/2028 | ||
Gaëlle Varkas | Director22/09/2022 → 24/09/2026Secretaris generaal22/09/2022 → 2024 accountsended | ||
Kristof Thevissen | Director17/11/2020 → 24/09/2026 | ||
Maria Simona Stoenoiu | Director17/11/2020 → 24/09/2026 | ||
Nisha Limaye | Director22/09/2022 → 24/09/2026 | ||
Stéphanie de Montjoye | Director22/09/2022 → 24/09/2026 | ||
Valérie Badot | Director17/11/2020 → 24/09/2026Chairman of the board of directors17/11/2020 → 2021 accountsended | ||
Yves Piette | Director17/11/2020 → 24/09/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Rik Lories | Director19/09/2024 → 2024 accounts | ||
Alla Ishchenko | Director17/11/2020 → 2023 accounts | ||
Anne Durnez | Director17/11/2020 → 2023 accounts | ||
Dirk Elewaut | Director17/11/2020 → 19/09/2024 |
Other companies at this address
Avenue Winston Churchill 11 1180 Uccle| Company | CBE no. |
|---|---|
Acta Orthopaedica Belgica● Active | 0447.930.756 |
A.G.N.D.● Active | 0442.605.555 |
AG-TOP● Active | 0808.723.444 |
Aponte Shipping Co● Liquidation | 0414.501.487 |
| 0774.793.537 | |
| 0406.521.852 | |
BATI PROFF● Active | 0767.973.348 |
| 0423.435.484 | |
| 0468.138.628 | |
| 0756.990.572 | |
| 0806.643.486 | |
belgian society of lymphology● Active | 0651.602.745 |
BELGIAN SURGICAL INTERNET COMMITTEE● Liquidation | 0475.107.483 |
| 0457.952.638 | |
| 0459.240.857 | |
| 0421.529.831 | |
| 0458.535.331 | |
CANNELLE● Active | 0435.623.931 |
CéThéo Management● Active | 0808.704.737 |
| 0401.939.096 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/07/2026 | 16/07/2025 | 09/07/2024 | 08/06/2023 | 15/07/2022 | 14/07/2021 |
| General meeting | 18/05/2026 | 19/05/2025 | 27/05/2024 | 15/05/2023 | 13/06/2022 | 21/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 18/05/2026 | 15/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 19/05/2025 | 16/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 27/05/2024 | 09/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 15/05/2023 | 08/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 13/06/2022 | 15/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 21/06/2021 | 14/07/2021 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202520 active · 15 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Charlotte Baert | Director17/11/2020 → 01/09/2028 | ||
Clio Ribbens | Director19/09/2024 → 01/09/2028 | ||
Isabelle de Wergifosse | Director17/11/2020 → 01/09/2028 | ||
Jan Lenaerts | Director17/11/2020 → 01/09/2028Chairman of the board of directors17/11/2020 → 2023 accountsended | ||
Karin Melsens | Director19/09/2024 → 01/09/2028 | ||
Laurent Meric de Bellefon | Chairman of the board of directors19/09/2024 → 24/09/2026Voorzitter19/09/2024 → 2024 accountsendedDirector17/11/2020 → 2023 accountsended | ||
Nicolaas Aerts | Director19/09/2024 → 01/09/2028 | ||
Olivier Malaise | Director19/09/2024 → 01/09/2028 | ||
Patrick Durez | Director17/11/2020 → 01/09/2028Penningsmeester19/09/2024 → 2024 accountsended | ||
Patrick Verschueren | Director19/09/2024 → 01/09/2028Vice-chairman of the board of directors17/11/2020 → 2023 accountsended | ||
Philip Remans | Director19/09/2024 → 01/09/2028 | ||
Rik Dories | Director19/09/2024 → 01/09/2028 | ||
Vanessa Smith | Director19/09/2024 → 01/09/2028 | ||
Gaëlle Varkas | Director22/09/2022 → 24/09/2026Secretaris generaal22/09/2022 → 2024 accountsended | ||
Kristof Thevissen | Director17/11/2020 → 24/09/2026 | ||
Maria Simona Stoenoiu | Director17/11/2020 → 24/09/2026 | ||
Nisha Limaye | Director22/09/2022 → 24/09/2026 | ||
Stéphanie de Montjoye | Director22/09/2022 → 24/09/2026 | ||
Valérie Badot | Director17/11/2020 → 24/09/2026Chairman of the board of directors17/11/2020 → 2021 accountsended | ||
Yves Piette | Director17/11/2020 → 24/09/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Rik Lories | Director19/09/2024 → 2024 accounts | ||
Alla Ishchenko | Director17/11/2020 → 2023 accounts | ||
Anne Durnez | Director17/11/2020 → 2023 accounts | ||
Dirk Elewaut | Director17/11/2020 → 19/09/2024 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates27/03/2026ONTSLAGEN - BENOEMINGEN
- Mandates26/10/2021ONTSLAGEN - BENOEMINGEN
- Other14/02/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other14/02/2020STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates31/10/2018ONTSLAGEN - BENOEMINGEN
- Mandates31/10/2018DEMISSIONS, NOMINATIONS
- Mandates02/12/2016ONTSLAGEN - BENOEMINGEN
- Mandates02/12/2016DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Winston Churchill 11 bte 30, 1180 UccleCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00293227 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIECurrent | CBE | |
| De Koninklijke Belgische Vereniging voor Reumatologie (KBVR) | accounts 2021 → 2025 | Accounts 2025 · 2026-00293227 |
| SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE | accounts 2020 | Accounts 2020 · 2021-34800155 |
Events
- 2025Annual accounts 2025-348,8 k €↓
- 2024Annual accounts 2024188,1 k €↓
- 2023Annual accounts 2023213,5 k €↑
- 2022Annual accounts 202231,9 k €↑
- 2021Annual accounts 2021-23,5 k €↓
- 2021Name changeDe Koninklijke Belgische Vereniging voor Reumatologie (KBVR)
- 2020Annual accounts 2020-9,8 k €
- 13/02/1969IncorporationNon-profit organization